Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Acme Formulation is a prominent Indian contract development and manufacturing organization (CDMO) that provides comprehensive pharmaceutical manufacturing services. The company specializes in the development and production of diverse dosage forms, including tablets, capsules, sterile injectables, and topical ointments. Operating out of advanced facilities in Baddi, Himachal Pradesh, Acme Formulation adheres to stringent international quality standards such as EU-GMP and WHO-GMP. They partner with global pharmaceutical firms to deliver high-quality generic and branded formulations across multiple therapeutic areas. In 2021, the Carlyle Group acquired a significant stake in the company to accelerate its expansion into complex generics and sterile products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Acme Formulation.